23 October, 2014 by The TZ Newswire Staff Comments Off on Stericycle, Inc.’s Earnings: Turning Trash Into Treasure
Stericycle, Inc.’s Earnings: Turning Trash Into Treasure
Stericycle’s third-quarter results improved thanks to M&A and rising disposal volume at doctor’s offices and hospitals.
23 October, 2014 by The TZ Newswire Staff Comments Off on Why Gold Is Undervalued
Why Gold Is Undervalued
Submitted by Alisdair Mcleod via Peak Prosperity,
Gold has been in a bear market for three years. Technical analysts are asking themselves whether they should call an end to this slump on the basis of the “triple-bottom” recently made at $1180/oz, or if they should be wary of a coming downside break beneath that level. The purpose of this article is to look at the drivers of the gold price and explain why today’s market value is badly reflective of gold’s true worth.
23 October, 2014 by The TZ Newswire Staff Comments Off on Everything You Need To Know About Blue Chip Earnings In One (Ugly) Table
Everything You Need To Know About Blue Chip Earnings In One (Ugly) Table
With today’s exuberance around earnings (notably forgetting the reality of various bellwether fails), we thought it appropriate to get some context on just what the “market stalwarts'” results look like in context.
23 October, 2014 by The TZ Newswire Staff Comments Off on Netgear’s Earnings: Solid Quarter Sends Mixed Signals
Netgear’s Earnings: Solid Quarter Sends Mixed Signals
Netgear beat expectations on both the top and bottom lines, but offered weak forward guidance. Here’s why.
23 October, 2014 by The TZ Newswire Staff Comments Off on Touch ID Is in the New Apple iPad: How You Can Invest in the Booming Fingerprint Sensor Market
Touch ID Is in the New Apple iPad: How You Can Invest in the Booming Fingerprint Sensor Market
The market for fingerprint sensors is poised to quadruple by 2020. How can you capitalize?
23 October, 2014 by The TZ Newswire Staff Comments Off on BioMarin Pharmaceutical Inc. Earnings: Striving to Be a Blockbuster Company
BioMarin Pharmaceutical Inc. Earnings: Striving to Be a Blockbuster Company
A solid third quarter puts BioMarin on target for more than $700 million in revenue this year, within striking distance of $1 billion in annual revenue.
23 October, 2014 by The TZ Newswire Staff Comments Off on Doctor tests positive for Ebola in NYC
Doctor tests positive for Ebola in NYC
A doctor in New York City who was recently treating Ebola patients in Guinea has himself tested positive for the virus.